rss
BMJ Case Reports 2018; doi:10.1136/bcr-2018-224169
  • Rare disease
  • CASE REPORT

Neuropsychological assessment as an objective tool to monitor treatment response in anti-N-methyl-D-aspartate receptor encephalitis

  1. Stephen VanHaerents4,5
  1. 1 Psychiatry and Behavioral Sciences, Northwestern Memorial Hospital, Chicago, Illinois, USA
  2. 2 Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
  3. 3 Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA
  4. 4 Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
  5. 5 Department of Neurology, Northwestern Memorial Hospital, Chicago, Illinois, USA
  1. Correspondence to Dr Stephen VanHaerents, svanhaer{at}gmail.com
  • Accepted 29 May 2018
  • Published 8 June 2018

Summary

We report a 1-year follow-up of a young woman with anti-N-methyl-D-aspartate receptor encephalitis. Management of autoimmune encephalitis remains challenging as objective and clinically relevant biomarkers are sought, which allow for the monitoring of treatment response. While further investigation is required, we believe that this case highlights the importance of following a comprehensive neuropsychological profile as a clinically relevant biomarker to guide therapeutic decision-making. By relying on the neuropsychological assessment of the patient, treatment with more toxic medications was avoided and her antiepileptic drug regimen was simplified.

Footnotes

  • Contributors ES prepared the manuscript and performed the neuropsychological assessments. MB supervised ES neuropsychological assessments and critically reviewed the manuscript. JL provided clinical guidance to this case and critically reviewed the manuscript. SVH supervised the project, clinically manages the patient and critically reviewed the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests SV reports other from SAGE Therapeutics, outside the submitted work; Clinical Trial for super refractory status epileptics.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog

Navigate This Article